[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362032-105":59,"doc-detail-362032-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","id1-promotes-the-progression-of-esophageal-cancer-via-modulating-ptenyapgalectin-3-signaling-pathway-induced-proliferation-and-immune-suppression","ID1 promotes the progression of esophageal cancer via modulating PTEN/YAP/galectin-3 signaling pathway induced proliferation and immune suppression","","ID1 is a transcription factor overexpressed in multiple cancers, but its mechanism in esophageal cancer remains unclear. The study tests the hypothesis that ID1 drives esophageal cancer progression by regulating the PTEN/YAP/galectin-3 axis, increasing tumor proliferation while causing immune suppression. Bioinformatics predicts gene interactions; western blotting, immunofluorescence, CCK-8, macrophage engulfment assays, and mouse tumor transplantation with immunohistochemistry validate ID1 effects. ID1 increases Galectin-3, Myc, CD47, and cyclin-A1 while decreasing NFIC, PTEN, and p-YAP, and reverses with PTEN agonists and YAP inhibitors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/id1-promotes-the-progression-of-esophageal-cancer-via-modulating-ptenyapgalectin-3-signaling-pathway-induced-proliferation-and-immune-suppression/362032/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/id1-promotes-the-progression-of-esophageal-cancer-via-modulating-ptenyapgalectin-3-signaling-pathway-induced-proliferation-and-immune-suppression/362032.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What hypothesis explains how ID1 affects esophageal cancer progression?","Question",{"text":112,"@type":113},"The study hypothesizes that ID1 regulates the PTEN/YAP/galectin-3 axis to induce tumor proliferation and immune suppression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which experimental methods were used to validate ID1’s role?",{"text":117,"@type":113},"Bioinformatics predicted gene interactions; western blotting and immunofluorescence assessed protein levels; CCK-8 measured tumor cell proliferation; macrophage phagocytosis was tested using engulfment assays; and in vivo subcutaneous tumor transplantation with immunohistochemistry was performed.",{"name":119,"@type":110,"acceptedAnswer":120},"How does altering ID1 expression change PTEN/YAP/Galectin-3 pathway markers and outcomes?",{"text":121,"@type":113},"ID1 overexpression decreases NFIC, PTEN, and p-YAP while increasing Galectin-3, Myc, CD47, and cyclin-A1, enhancing cancer cell proliferation and macrophage phagocytic ability; PTEN agonists and YAP inhibitors reduce proliferation and weaken macrophage phagocytosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362032,1790197139,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nID1 promotes the progression of esophageal cancer via modulating PTEN/YAP/galectin-3 signaling pathway induced proliferation and immune suppression  \nYing Ji1, Zhaoyang Yan1, Zhanjie Gao1, Weiwei Li1 & Xinjian Xu1,2􀀍  \nEsophageal cancer (EC) is a highly aggressive malignancy. ID1, a transcription factor overexpressed in multiple cancers, promotes tumor progression, but its molecular mechanisms in EC remain unclear. We hypothesized that ID1 drives EC progression by regulating the PTEN/YAP/Galectin-3 axis to induce proliferation and immune suppression. Bioinformatics analysis was employed to predict and validate the interactions between genes in esophageal cancer; protein expression levels, including ID1 and PTEN, were assessed using western blotting and immunofluorescence; tumor cell proliferation was evaluated with the CCK-8 assay; and macrophage phagocytosis function was tested through engulfment assays. Additionally, the effects of ID1 on esophageal cancer were investigated using subcutaneous tumor transplantation experiments in nude mice and immunohistochemical staining experiments of human cancerous tissues and peritumoral tissues. ID1 was found to inhibit the action  \nof NFIC. When ID1 was overexpressed, there was a decrease in the expression levels of NFIC, PTEN, and p-YAP, and an increase in the levels of Galectin-3, Myc, CD47, and cyclin-A1 . Overexpression of ID1 significantly enhanced the proliferation of esophageal cancer cells and improved the phagocytic ability of macrophages, whereas after treatment with PTEN agonists andYAP inhibitors, the proliferation of esophageal cancer cells decreased markedly, and the phagocytic ability of macrophages was reduced. Furthermore, overexpression of ID1 promoted the progression of esophageal cancer, and the expression of ID1 in human cancerous tissues was significantly higher than that in peritumoral tissues. ID1 promotes the progression of esophageal cancer by inducing proliferation and immune suppression through regulation of the PTEN/YAP/Galectin-3 signaling pathway.  \nKeywords ID1, PTEN/YAP/Galectin-3 signaling pathway, NFIC, Immune suppression, Esophageal cancer  \nEsophageal cancer is one of the most common and deadly malignant tumors worldwide, ranking sixth among all cancer-related deaths globally1. Due to the absence of specific symptoms or signs in the early stages, its overall prognosis is extremely poor, with a five-year overall survival rate of approximately 15% . Histologically, esophageal cancer is primarily classified into squamous cell carcinoma (ESCC) and adenocarcinoma (EAC) . While ESCC predominates globally, the incidence of esophageal adenocarcinoma (EAC) has risen dramatically in Western populations over recent decades and represents a distinct clinical entity2. The etiology and pathogenesis of esophageal adenocarcinoma may be associated with various factors, including chronic gastroesophageal reflux disease (GERD), Barrett’s esophagus, obesity, diet, and genetic predisposition3,4. In Western countries, EAC development is closely linked to these specific risk factors and exhibits unique molecular characteristics5,6, which remain incompletely understood. Therefore, it is essential to conduct in-depth studies on the molecular mechanisms associated with esophageal cancer to explore potential novel biomarkers and provide new strategies for its diagnosis and treatment.  \nID1 is a transcription factor that plays a key role in cell proliferation, differentiation, and survival. Studies have shown that ID1 is highly expressed in various cancers, and its overexpression is associated with tumor  \n1Department of thoracic surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. 2The Fourth Hospital, Hebei Medical University, No. 12, Jiankang Road, Chang ’an District, 050011 Shijiazhuang, Hebei, China. 􀀍 email: [syxuxinjian0799@hebmu.edu.cn](syxuxinjian0799@hebmu","cbCaig0sjVEOmY2R","https://ap.wps.com/l/cbCaig0sjVEOmY2R","pdf",5183134,13,"English","# Introduction\n# Molecular background and rationale\n## ID1 in cancer biology\n## Galectin-3 and HIPPO/YAP signaling\n## NFIC and PTEN tumor suppression\n# Experimental design and validation approach\n## Interaction prediction and protein expression assays\n## Proliferation and macrophage engulfment assays\n## In vivo tumor transplantation and immunohistochemistry","[{\"question\":\"What hypothesis explains how ID1 affects esophageal cancer progression?\",\"answer\":\"The study hypothesizes that ID1 regulates the PTEN/YAP/galectin-3 axis to induce tumor proliferation and immune suppression.\"},{\"question\":\"Which experimental methods were used to validate ID1’s role?\",\"answer\":\"Bioinformatics predicted gene interactions; western blotting and immunofluorescence assessed protein levels; CCK-8 measured tumor cell proliferation; macrophage phagocytosis was tested using engulfment assays; and in vivo subcutaneous tumor transplantation with immunohistochemistry was performed.\"},{\"question\":\"How does altering ID1 expression change PTEN/YAP/Galectin-3 pathway markers and outcomes?\",\"answer\":\"ID1 overexpression decreases NFIC, PTEN, and p-YAP while increasing Galectin-3, Myc, CD47, and cyclin-A1, enhancing cancer cell proliferation and macrophage phagocytic ability; PTEN agonists and YAP inhibitors reduce proliferation and weaken macrophage phagocytosis.\"}]","ID1 promotes the progression of esophageal cancer via modulating PTEN/YAP/galectin-3 signaling pathway induced proliferation and immune suppression | PDF",1790146313,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d409901857b4901722d0f2d25ca0ce89.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75503541d92642a12767154a51b4cfda.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99a4a85e2d538b02042ea792b23c2c9f.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ab026449e573f24945792df9eb61f55.webp",980,1287]